Komori
Share Issuance and Disposal4547KISSEI PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Notice Regarding Completion of Payment for the Disposal of Treasury Shares as Restricted Stock to the Employee Stock Ownership Association and Partial Forfeiture

Payment for the disposal of treasury shares as restricted stock for the Employee Stock Ownership Association has been completed. Due to partial forfeiture by association members, the number of shares disposed of decreased from 504,300 to 449,050, and the total disposal value decreased from ¥2,415,597,000 to ¥2,150,949,500.

Worth reading
36Immaterial
Scored from 4 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
55250
decrease in shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Disposal of treasury shares as restricted stock for the Employee Stock Ownership Association

Who receives how much

449,050 common shares of the Company (before change: 504,300 shares)

Kissei Group Employee Stock Ownership Association: 449,050 shares

The lower thin line represents the existing number of shares to which these shares will be added.

¥4,790 per share
Total issue value

¥2,150,949,500 (before change: ¥2,415,597,000)

Categories and Number of Persons Covered
Employees of the Company and its subsidiaries (number of people: Not disclosed)
Payment date
10 August 2026
Impact on Business Performance
There will be no change to the earnings forecast for the current fiscal year as a result of this transaction.
Details of issuance or disposal
ItemDetails
Type of issuance or disposalDisposal of treasury shares as restricted stock for the Employee Stock Ownership Association
Number of shares to be issued or disposed of449,050 common shares of the Company (before change: 504,300 shares)
Issue price and disposal price¥4,790 per share
Total issue value¥2,150,949,500 (before change: ¥2,415,597,000)
Payment date10 August 2026
Intended allotteeKissei Group Employee Stock Ownership Association: 449,050 shares
Categories and Number of Persons CoveredEmployees of the Company and its subsidiaries (number of people: Not disclosed)
Impact on Business PerformanceThere will be no change to the earnings forecast for the current fiscal year as a result of this transaction.
Items this document does not state (20)
Amount of funds to be raisedEstimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offering

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

This resulted from the finalization of the number of members of the Employee Stock Ownership Association who agreed to the restricted stock grant program for employees of the Company and its subsidiaries through the Association.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Completion of Payment for the Disposal of Treasury Shares as Restricted Stock to the Employee Stock Ownership Association and Partial Forfeiture | KISSEI PHARMACEUTICAL CO.,LTD. (4547) timely disclosure | Komori